Dengue versus multisystem inflammatory syndromewhen the grey zone gets thinner. Cureus. 2021; 13:e20276. COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT: Reply W e appreciate your interest in our case report entitled "COVID-19 Vaccineinduced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/ CT." 1 Regarding the diagnosis of the case,we agree with previous comments that a variety of infectious diseases share features of COVID-19 vaccine-induced multisystem inflammatory syndrome (MIS). Dengue could be one of the differential diagnoses because it usually presents with fever, arthralgia, myalgia, skin rash, and laboratory features of systemic inflammation. While dengue is an infectious disease caused by dengue viruses, Korea is not an endemic area of dengue with a very small number of imported cases. 2 The patient was doing well before vaccination with the BNT162b2 mRNA COVID-19 vaccine without evidence of immune deficiency. He did not show skin rash, eye pain, or low blood pressure, which are common in dengue. The infection specialist ruled out the possibility of infectious diseases after thorough evaluation including immune status. Thus, it is less likely that the present case is dengue or other infectious diseases. Given that fever and other features of systemic inflammation developed just after vaccination with the COVID-19 vaccine, the case is more likely to be COVID-19 vaccineinduced MIS. Because there is no confirmation test for the diagnosis of COVID-19 vaccine-induced MIS, a temporal relationship between vaccination and the development of symptoms should be considered with the exclusion of the other differential diagnoses. 3